D Ribatti. Show Affiliations »
Abstract
Entities: Disease Gene
Mesh: See more » Erythropoietin/therapeutic useHematologic Neoplasms/drug therapyHematologic Neoplasms/pathologyHumansMyelodysplastic Syndromes/drug therapyMyelodysplastic Syndromes/etiologyMyelodysplastic Syndromes/pathologyNeovascularization, Pathologic/pathologyReceptors, Erythropoietin/metabolism
Substances: See more » Receptors, ErythropoietinErythropoietin
Year: 2002 PMID: 12200722 DOI: 10.1038/sj.leu.2402623
Source DB: PubMed Journal: Leukemia ISSN: 0887-6924 Impact factor: 11.528